The aims of the study were to determine the accuracy of fluorodeoxyglucose positron emission tomography (FDG-PET) in detecting pulmonary metastasis through video-assisted thoracoscopic surgery (VATS), a technique that allows the excisional biopsy of small pulmonary nodules in patients with known malignancies. Materials and Methods: Between October 2007 and April 2010, 28 patients with known malignancies and small pulmonary nodules underwent VATS excisional biopsies. All patients were in follow-up for a previously treated malignancy. The malignancies included the following: colorectum (9), breast (6), head and neck (5), stomach (3), lymph (1), ovary (1), uterus (1), bladder (1), and liver (1). Results: There were 16 men and 12 women whose mean age was 56.7 years old (range, 38 to 77 years). The sizes of the mean nodules removed were 11.3 mm (range, 7 to 21 mm). Diagnoses included metastatic (11), bronchioloalveolar carcinoma (1), primary adenocarcinoma (1), pulmonary tuberculosis (6), fibrosis (5), organizing pneumonia (3), lymphoid hyperplasia (1). Among these lesions, 46.4% were malignant. Conclusion: True positive FDG-PET was 39.2%. FDG-PET is not a sensitive test in the evaluation of patients with a history of an extrathoracic malignancy and newly diagnosed small pulmonary nodules. VATS excision allows the early diagnosis of small pulmonary nodules, with low morbidity, in patients with known malignancies.
INTRODUCTION
During follow-up, patients with known malignancies commonly undergo screening studies to detect recurrence or metastasis. 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is increasingly being used for screening, often in conjunction with computed tomography (CT).
Overall, in the setting of an indeterminate nodule greater than 1 cm, FDG-PET has a sensitivity of 96.8% and specificity of 77.8% in the detection of malignancy [1] . However, lit- tle is known about the accuracy of FDG-PET in detecting extrathoracic malignancies that have spread to the lungs.
Recently, video assisted thoracoscopic surgery (VATS) has been performed for the resection of small pulmonary lesions.
This technique is less painful and invasive, and is thus more acceptable to patients than thoracotomy.
In this study, we performed VATS in cases of suspected pulmonary metastasis from known malignancy. The aims of the study were to determine the accuracy of FDG-PET in detecting pulmonary metastasis through the VATS technique, which allows the excisional biopsy of small pulmonary nodules in patients with known malignancies.
MATERIALS AND METHODS
Between July 2007 and April 2010, we prospectively studied 28 patients who were in follow-up care for a previously treated malignancy. The malignancies included the colorectum (9), breast (6), head and neck (5), stomach (3), lymph (1), ovary, uterus, liver, bladder ( In operating room, the patient was positioned for VATS.
The operative lung was isolated. After prepping and draping, three working ports were created and the lung was visualized.
An autosuture stapling device that was 45 or 60 mm long and used 4. 
RESULTS
There were 16 men and 12 women whose median age was 56.7 years old (range, 38 to 77 years). All lesions were resected on the first attempt using standard VATS wedge ex- Table 2) .
Overall sensitivity of 18F-FDG-PET in the 28 patients who underwent resection was 39.2%. No association was found between malignant and benign tissue in the SUVmax and tumor sizes (Table 3) . A receiver operating characteristics curve was constructed and a cut-off value was determined for the diagnosis of metastatic small pulmonary nodules. Using the cut-off of 2.5 for the SUVmax, the sensitivity and specificity for predicting metastatic small pulmonary nodules were
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Fig. 1.
Receiver operating characteristics (ROC) curve for maximal standard uptake value (95% confidence interval).
Fig. 2. Receiver operating characteristics (ROC) curve for tumor size (95% confidence interval).
60.0% and 43.7%, respectively. Using the cut-off of 1 mm for tumor size, the sensitivity and specificity for predicting metastatic small pulmonary nodules were 45.0% and 50.0%, respectively (Figs. 1, 2 ).
DISCUSSION
The presumed diagnosis of small pulmonary nodules is based on several factors: the age of the patient, associated symptoms, appearance of the lesion on a radiograph, and the length of time the lesion has been present. A single pulmonary nodule is more likely to be malignant in patients with known cancer [2] .
The idea of whole body cancer surveillance is very appealing and has, for some, compelled the use of FDG-PET as a screening tool for recurrence of various malignancies.
Integrated FDG-PET/CT can evaluate nodules as small as 7 or 8 mm in size. A high SUVmax, especially in a small pulmonary nodule, provides important information and helps guide therapy. Moreover, an integrated FDG-PET/CT may provide other targets (lymph nodes or M1 sites) that harbor metastatic disease that require biopsy prior to resection. The optimal value of the SUVmax for mediastinal and hilar lymph nodes has recently been evaluated [3] .
The usefulness of 18F-FDG-PET for differentiation of benign and malignant pulmonary lesions has been investigated in various studies [4] [5] [6] . The reported sensitivity and specificity of the 18F-FDG-PET ranges between 0.75 and 1.0.
SUVmax were significantly increased in malignant lesions compared to benign lesions [7] , and the value of 2.5 is accepted as the cut-off point for malignancy [8] .
SUV expresses FDG uptake by the lesion normalized according to the dose administered and the subject's body weight. In fact, having defined the many factors that can affect the uptake of labeled glucose and, therefore, the SUV, it
is not easy to establish fixed values that serve to distinguish − 38 − between the benign and malignant nature of a small pulmonary nodule [9] . Definitive diagnosis of lung lesions can sometimes not be made because of the inaccessibility of the true lesion or the inadequacy of the sample size [11, 12] . Bronchoscopic biopsy and percutaneous needle biopsy under CT are useful methods; however, they are not always able to yield a definite diagnosis, since results depend on the technique and tumor size.
Moreover, specimens may be too small to be diagnosed, and negative biopsy results might require further examination.
Surgical lung biopsy is considered the final diagnostic modality to be used in patients with undiagnosed small pulmonary nodules.
VATS has replaced thoracotomy as the preferred surgical modality for diagnostic excisional biopsy of indeterminate pulmonary nodules because of decreased morbidity. We do use finger palpation through the port if we have difficulty identifying the lesion or the margins. We also use long
Roberts haemostatic clamps to feel the surface of the lung when we search for the lesion. It is generally accepted that VATS biopsy reduces postoperative pain and disability, causes fewer operative scars, and is equally effective in obtaining histologic diagnosis [13, 14] .
CONCLUSION
In patients with a history of an extrathoracic malignancy and newly diagnosed small pulmonary nodules, FDG-PET is not sensitive enough to dictate treatment. The results of this study in patients with known malignant disease reinforce the need for timely VATS wedge excision of small pulmonary nodules.
